Board Meeting Outcome held for Standalone Financial Result for 30th September, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.4 pts more than Nifty Microcap 250 and 0.5 pts more than its Commodity Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Padmanabh Industries reported a sharp revenue decline in Q2 FY26, with operating revenue falling to ₹11.50 lakhs from ₹24.75 lakhs in the same quarter last year (roughly a 54% drop). The company swung to a wider net loss of ₹19.39 lakhs for the quarter and ₹21.44 lakhs for H1 FY26, compared with losses of ₹2.05 lakhs and ₹6.61 lakhs respectively a year ago. The balance sheet is deeply stressed — reserves are negative at ₹(633.97) lakhs, overall equity is in the red at ₹(26.22) lakhs, and total borrowings have ballooned to about ₹652 lakhs (up from roughly ₹61 lakhs at March-end). Cash and equivalents have also slipped to ₹5.83 lakhs. The auditor (S K Bhavsar & Co.) issued a clean limited review opinion but flagged an Emphasis of Matter on pending verification of trade receivables, trade payables, loans and advances, investments, and GST-related documentation.
Widening losses, plunging revenue, and a negative net worth raise serious red flags about the company's financial viability and could pressure the stock. Shareholders should watch closely for any going-concern commentary, fundraising, or asset-sale activity in coming quarters.